Pharma Journalist -

TRON Group, Inc. and Nanopharmaceutics, Inc. ("Nano"), a privately-held clinical-stage pharmaceutical development company incorporated in Florida, announced today the signing of a…
Read More...

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unresectable or metastatic non-small cell lung…
Read More...

Ceapro Inc., a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced it has entered…
Read More...

Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, announced that the U.S. Food and Drug Administration (FDA) granted Orphan…
Read More...

GentiBio, Inc., an engineered regulatory T cells (Tregs) company,  announced that it has entered into a collaboration with Bristol Myers Squibb to develop new engineered Treg therapies…
Read More...

SAE Media Group: Exclusive interview with Geraint Davies, Principal Human Factors Engineer, Roche ahead of the Wearable Injectors & Connected Devices Conference SAE Media Group’s…
Read More...

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune…
Read More...

Gilead Sciences, Inc. and MiroBio announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire MiroBio for approximately $405 million in…
Read More...

Acadia Pharmaceuticals Inc. announced that the Company has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its supplemental New Drug…
Read More...

Poseida Therapeutics, Inc. announced it has entered into a broad strategic collaboration and license agreement with Roche, focused on developing allogeneic CAR-T therapies directed to…
Read More...